Caplin Point Lab

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE475E01026
NSEID: CAPLIPOINT
BSEID: 524742
View on NSE | View on BSE

INR

1,725.70

-6.25 (-0.36%)

BSENSE

Apr 29

BSE+NSE Vol: 51.06 k

{
  "main_header": {
    "sid": 640544,
    "name": "Caplin Point Lab",
    "stock_name": "Caplin Point Lab",
    "full_name": "Caplin Point Laboratories Ltd",
    "name_url": "stocks-analysis/caplin-point-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,725.70",
    "chg": -6.25,
    "chgp": "-0.36%",
    "dir": -1,
    "prev_price": "1,731.95",
    "mcapval": "13,120.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524742,
    "symbol": "CAPLIPOINT",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE475E01026",
    "curr_date": "Apr 29",
    "curr_time": "",
    "bse_nse_vol": "51.06 k",
    "exc_status": "Active",
    "traded_date": "Apr 29, 2026",
    "traded_date_str": "2026 04 29",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/caplin-point-lab-640544-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-3952876",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CaplinPointLabo_mojoScore_3952876.png",
        "date": "2026-04-19 10:10:37",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Caplin Point Laboratories Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3948250",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CaplinPointLabo_technicaldot_3948250.png",
        "date": "2026-04-16 08:03:58",
        "description": "Caplin Point Laboratories Ltd has experienced a notable shift in its technical momentum, reflected in a blend of mildly bearish and bullish signals across key indicators. Despite a 3.10% gain on the day, the company’s technical trend has transitioned from bearish to mildly bearish, prompting a reassessment of its near-term outlook within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Caplin Point Laboratories Ltd Faces Bearish Momentum Amid Technical Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-faces-bearish-momentum-amid-technical-downturn-3946616",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CaplinPointLabo_technicaldot_3946616.png",
        "date": "2026-04-15 08:02:57",
        "description": "Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum, signalling a bearish trend. Despite a strong long-term performance relative to the Sensex, recent technical indicators suggest caution for investors as the stock’s momentum deteriorates amid weakening moving averages and mixed signals from key oscillators."
      },
      {
        "title": "Caplin Point Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-3943968",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CaplinPointLabo_technicaldot_3943968.png",
        "date": "2026-04-13 08:02:26",
        "description": "Caplin Point Laboratories Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bearish signals across key indicators. Despite a 2.55% rise in the latest session to ₹1,705.10, the stock’s technical parameters suggest cautious investor sentiment amid a broader small-cap pharmaceutical sector backdrop."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-3937332",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CaplinPointLabo_mojoScore_3937332.png",
        "date": "2026-04-08 10:10:35",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 08 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Caplin Point Laboratories Gains 0.68%: 2 Key Events Shaping the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-gains-068-2-key-events-shaping-the-week-3932170",
        "imagepath": "",
        "date": "2026-04-04 16:06:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>30 Mar:</strong> Stock hits 52-week low of Rs.1,519.35</p>\n                    <p><strong>1 Apr:</strong> Opens with a 6.28% gap up, closing at Rs.1,573.70 (+4.10%)</p>\n                    <p><strong>2 Apr:</strong> Slight pullback to Rs.1,567.85 (-0.37%)</p>\n                    <p><strong>3 Apr:</strong> Week closes at Rs.1,567.85, up 0.68% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.1,557.20</div>\n                    </div>\n                    <div class=\"stat-item\">\n                   ..."
      },
      {
        "title": "Caplin Point Laboratories Ltd Opens 6.28% Higher in Sharp Gap Up, But Can the Technicals Support It?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-opens-strong-with-628-gap-up-on-1-april-2026-3927978",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CaplinPointLabo_gapup_3927978.png",
        "date": "2026-04-01 09:34:42",
        "description": ""
      },
      {
        "title": "Why is Caplin Point Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-caplin-point-laboratories-ltd-fallingrising-3926880",
        "imagepath": "",
        "date": "2026-03-31 01:37:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Caplin Point Laboratories has been under pressure over the past week, with the stock falling 3.60%, significantly underperforming the Sensex, which declined by only 1.03% in the same period. Over the last month, the stock's decline of 10.27% closely mirrors the Sensex's 10.33% drop, indicating sector-wide challenges. However, year-to-date, the stock has fallen 18.37%, outpacing the Sensex's 15.57% decline, and over the last year, the stock has plunged 24.38%, far exceeding the Sensex's 7.06% loss. This divergence highlights company-specific factors weighing on investor sentiment.</p>\n<p>On 30-Mar, the stock hit a new 52-week low of ₹1,502.45, marking a fresh nadir in its trading range. The share price has been declining for two consecu..."
      },
      {
        "title": "Caplin Point Laboratories Ltd Falls to 52-Week Low of Rs 1519.35 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-stock-falls-to-52-week-low-of-rs-151935-3924432",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CaplinPointLabo_priceRelatedfactors_3924432.png",
        "date": "2026-03-30 11:10:06",
        "description": "A sharp decline over the past two sessions has dragged Caplin Point Laboratories Ltd to a fresh 52-week low of Rs 1519.35, marking a 36.6% drop from its peak of Rs 2396.95 within the last year. This underperformance stands in stark contrast to the broader market, with the Sensex down just 6.34% over the same period."
      }
    ],
    "total": 599,
    "sid": "640544",
    "stock_news_url": "https://www.marketsmojo.com/news/caplin-point-laboratories-640544"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Apr-2026",
      "details": "Intimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2026",
      "details": "Intimation of closure of Trading Window commencing from April 01 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "13-Mar-2026",
      "details": "Press release regarding receipt of final approval by our subsidiary Caplin Steriles Limited from USFDA for the Potassium Phosphates Injection USP",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has declared <strong>150%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 19 Oct 16",
          "dt": "2016-10-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Caplin Point Laboratories Ltd is Rated Sell

2026-04-19 10:10:37

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Caplin Point Laboratories Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals

2026-04-16 08:03:58

Caplin Point Laboratories Ltd has experienced a notable shift in its technical momentum, reflected in a blend of mildly bearish and bullish signals across key indicators. Despite a 3.10% gain on the day, the company’s technical trend has transitioned from bearish to mildly bearish, prompting a reassessment of its near-term outlook within the Pharmaceuticals & Biotechnology sector.

Read full news article

Caplin Point Laboratories Ltd Faces Bearish Momentum Amid Technical Downturn

2026-04-15 08:02:57

Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum, signalling a bearish trend. Despite a strong long-term performance relative to the Sensex, recent technical indicators suggest caution for investors as the stock’s momentum deteriorates amid weakening moving averages and mixed signals from key oscillators.

Read full news article

Caplin Point Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-13 08:02:26

Caplin Point Laboratories Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bearish signals across key indicators. Despite a 2.55% rise in the latest session to ₹1,705.10, the stock’s technical parameters suggest cautious investor sentiment amid a broader small-cap pharmaceutical sector backdrop.

Read full news article

Caplin Point Laboratories Ltd is Rated Sell

2026-04-08 10:10:35

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 08 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Caplin Point Laboratories Gains 0.68%: 2 Key Events Shaping the Week

2026-04-04 16:06:00

Key Events This Week

30 Mar: Stock hits 52-week low of Rs.1,519.35

1 Apr: Opens with a 6.28% gap up, closing at Rs.1,573.70 (+4.10%)

2 Apr: Slight pullback to Rs.1,567.85 (-0.37%)

3 Apr: Week closes at Rs.1,567.85, up 0.68% for the week

Week Open

Rs.1,557.20

...

Read full news article

Caplin Point Laboratories Ltd Opens 6.28% Higher in Sharp Gap Up, But Can the Technicals Support It?

2026-04-01 09:34:42

Read full news article

Why is Caplin Point Laboratories Ltd falling/rising?

2026-03-31 01:37:49

Recent Price Movement and Market Context

Caplin Point Laboratories has been under pressure over the past week, with the stock falling 3.60%, significantly underperforming the Sensex, which declined by only 1.03% in the same period. Over the last month, the stock's decline of 10.27% closely mirrors the Sensex's 10.33% drop, indicating sector-wide challenges. However, year-to-date, the stock has fallen 18.37%, outpacing the Sensex's 15.57% decline, and over the last year, the stock has plunged 24.38%, far exceeding the Sensex's 7.06% loss. This divergence highlights company-specific factors weighing on investor sentiment.

On 30-Mar, the stock hit a new 52-week low of ₹1,502.45, marking a fresh nadir in its trading range. The share price has been declining for two consecu...

Read full news article

Caplin Point Laboratories Ltd Falls to 52-Week Low of Rs 1519.35 as Sell-Off Deepens

2026-03-30 11:10:06

A sharp decline over the past two sessions has dragged Caplin Point Laboratories Ltd to a fresh 52-week low of Rs 1519.35, marking a 36.6% drop from its peak of Rs 2396.95 within the last year. This underperformance stands in stark contrast to the broader market, with the Sensex down just 6.34% over the same period.